SEB Asset Management
RMD icon

SEB Asset Management’s ResMed RMD Stock Holding History

SEB Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.7M Sell
75,520
-71,210
-49% -$15.5M 0.06% 246
2026
Q2 		$28.6M Buy
146,730
+6,700
+5% +$1.39M 0.11% 168
2026
Q1 		$31.4M Buy
+140,030
New +$34.9M 0.13% 137

Other funds holding RMD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

SEB Asset Management's RMD Position: Q3 2026 in Review

SEB Asset Management reduced its ResMed (RMD) stake by 49% in Q3 2026, selling an estimated $15.5M and leaving 75,520 shares worth $16.7M. The position accounts for 0.06% of the portfolio, ranked #246.

SEB Asset Management first reported a position in RMD in Q1 2026 and has held it in 3 quarters since. The position peaked at $31.4M in Q1 2026. 741 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • SEB Asset Management held 75,520 shares of ResMed worth $16.7M as of Q3 2026.
  • SEB Asset Management sold 71,210 ResMed shares in Q3 2026, an estimated $15.5M.
  • ResMed made up 0.06% of SEB Asset Management's portfolio in Q3 2026, its #246 holding.
  • SEB Asset Management first reported a position in ResMed in Q1 2026 and has held it in 3 quarters since.
  • SEB Asset Management's ResMed position peaked at $31.4M in Q1 2026.
  • 741 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.